189 related articles for article (PubMed ID: 16021080)
1. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy.
Yie SM; Taylor RN; Librach C
Am J Obstet Gynecol; 2005 Jul; 193(1):204-8. PubMed ID: 16021080
[TBL] [Abstract][Full Text] [Related]
2. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
[TBL] [Abstract][Full Text] [Related]
4. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia.
Yie SM; Li LH; Li YM; Librach C
Am J Obstet Gynecol; 2004 Aug; 191(2):525-9. PubMed ID: 15343231
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders.
D'Anna R; Baviera G; Corrado F; Giordano D; Di Benedetto A; Jasonni VM
Obstet Gynecol; 2005 Aug; 106(2):340-4. PubMed ID: 16055585
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.
D'Anna R; Baviera G; Corrado F; Giordano D; De Vivo A; Nicocia G; Di Benedetto A
BJOG; 2006 Nov; 113(11):1264-9. PubMed ID: 17010118
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia.
Yu CK; Papageorghiou AT; Bindra R; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):158-62. PubMed ID: 15590441
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
[TBL] [Abstract][Full Text] [Related]
11. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
12. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.
Alegre E; Díaz-Lagares A; Lemaoult J; López-Moratalla N; Carosella ED; González A
Hum Immunol; 2007 Aug; 68(8):661-7. PubMed ID: 17678720
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G circulates in maternal blood during pregnancy.
Hunt JS; Jadhav L; Chu W; Geraghty DE; Ober C
Am J Obstet Gynecol; 2000 Sep; 183(3):682-8. PubMed ID: 10992193
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.
McElrath TF; Lim KH; Pare E; Rich-Edwards J; Pucci D; Troisi R; Parry S
Am J Obstet Gynecol; 2012 Nov; 207(5):407.e1-7. PubMed ID: 22981320
[TBL] [Abstract][Full Text] [Related]
15. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
Idris I; Srinivasan R; Simm A; Page RC
Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
[TBL] [Abstract][Full Text] [Related]
16. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy.
Steinborn A; Varkonyi T; Scharf A; Bahlmann F; Klee A; Sohn C
Am J Reprod Immunol; 2007 Apr; 57(4):277-86. PubMed ID: 17362389
[TBL] [Abstract][Full Text] [Related]
17. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction.
Cetin I; Cozzi V; Papageorghiou AT; Maina V; Montanelli A; Garlanda C; Thilaganathan B
Acta Obstet Gynecol Scand; 2009; 88(7):846-9. PubMed ID: 19544202
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HLA-G protein in trophoblast cells].
Wang YQ; Chen SL; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1488-90. PubMed ID: 16354612
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
20. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
